Veinlite NEO®

NEO uses through-the-body transillumination specifically calibrated for neonatal tissue. At this age, traditional side-illumination is less effective due to tissue characteristics. NEO's unique approach allows visualization of both veins AND arteries, which is critical when working with umbilical vessels or avoiding arterial puncture.

In neonatal emergency care and NICU settings, distinguishing between arterial and venous structures is crucial—especially around the umbilicus for catheter placement, or when accessing limb vessels. NEO's through-body illumination reveals both types of vessels, improving safety and procedural success.

While umbilical vein catheterization is valuable for resuscitation and central access, peripheral IV is often preferred when possible (less invasive, fewer complications like portal vein thrombosis or infection). NEO makes peripheral access more achievable, reserving umbilical access for when truly necessary.

When umbilical access IS needed, NEO helps identify the umbilical vein (larger, thin-walled, single) versus the umbilical arteries (smaller, thick-walled, paired) during catheter insertion. Clear vessel identification reduces complications and improves catheter placement success.

Absolutely. Factors like prematurity, low birth weight, dehydration, edema, and darker skin tones all make neonatal IV access challenging. Studies show transillumination significantly improves success rates in these high-risk situations, making peripheral access possible when it might otherwise fail.

Very. When neonatal resuscitation requires vascular access, time is critical. While emergency umbilical vein catheterization is standard, NEO can help identify the umbilical vein quickly and may reveal peripheral options if umbilical access is contraindicated or unsuccessful.

Neonates, especially premature infants, have extremely fragile veins and delicate skin. Multiple needle sticks increase infection risk, cause tissue damage, deplete available access sites, and add procedural stress. NEO's improved visualization reduces attempts needed for successful access.

Yes, exceptionally well. Premature infants have the thinnest skin and tissue, making through-body transillumination particularly effective. They're also at highest risk for difficult access (documented in DIVA scoring for prematurity), making NEO especially valuable in NICU settings.

Yes—a unique benefit. By revealing both veins and arteries, NEO helps you avoid inadvertent arterial puncture. You can also identify thrombosed vessels, areas with poor venous return, or anatomical variations that make certain sites unsuitable before attempting insertion.

Many NICU patients require IV access for weeks or months. Every failed attempt depletes available sites and compromises vessels. NEO's improved first-attempt success preserves vein capital, ensuring adequate access sites remain available throughout their hospital stay.